4
Changes in Ownership
Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-19-029514
Chief Executive Officer bought 995 shares at $6.99 ($6,955)
From the SEC's structured data for this filing
Trades in this filing
Cohen Yuval · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-05-13 | Purchase : show line 1 in the form | +995 | $6.99 | $6,955 | 64,185 | D |
| Open-market purchases · 995 sh · avg $6.99 · $6,955 | ||||||
Loading xslF345X03/doc4.xml…